vs
Encompass Health Corp（EHC）与FIVE BELOW, INC（FIVE）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是FIVE BELOW, INC的1.5倍（$1.5B vs $1.0B），Encompass Health Corp净利率更高（9.5% vs 3.5%，领先5.9%），FIVE BELOW, INC同比增速更快（23.1% vs 9.9%），Encompass Health Corp自由现金流更多（$116.7M vs $-133.2M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -11.9%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Five Below是美国特色折扣礼品连锁品牌，2002年成立，总部位于宾夕法尼亚州费城，主要面向青少年消费群体，旗下绝大多数商品定价不超过5美元，另有少量精选商品最高定价40美元，目前在全美拥有超过1850家线下门店。
EHC vs FIVE — 直观对比
营收规模更大
EHC
是对方的1.5倍
$1.0B
营收增速更快
FIVE
高出13.1%
9.9%
净利率更高
EHC
高出5.9%
3.5%
自由现金流更多
EHC
多$249.9M
$-133.2M
两年增速更快
EHC
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.0B |
| 净利润 | $146.1M | $36.5M |
| 毛利率 | — | 33.8% |
| 营业利润率 | 16.7% | 4.2% |
| 净利率 | 9.5% | 3.5% |
| 营收同比 | 9.9% | 23.1% |
| 净利润同比 | 20.8% | 2063.9% |
| 每股收益（稀释后） | $1.43 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCFIVE
| Q4 25 | $1.5B | $1.0B | ||
| Q3 25 | $1.5B | $1.0B | ||
| Q2 25 | $1.5B | $970.5M | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.4B | $843.7M | ||
| Q3 24 | $1.4B | $830.1M | ||
| Q2 24 | $1.3B | $811.9M | ||
| Q1 24 | $1.3B | $1.3B |
净利润EHCFIVE
| Q4 25 | $146.1M | $36.5M | ||
| Q3 25 | $126.5M | $42.8M | ||
| Q2 25 | $142.1M | $41.1M | ||
| Q1 25 | $151.5M | $187.5M | ||
| Q4 24 | $120.9M | $1.7M | ||
| Q3 24 | $108.2M | $33.0M | ||
| Q2 24 | $114.1M | $31.5M | ||
| Q1 24 | $112.5M | $202.2M |
毛利率EHCFIVE
| Q4 25 | — | 33.8% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 40.2% | ||
| Q4 24 | — | 30.6% | ||
| Q3 24 | — | 32.7% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | — | 41.2% |
营业利润率EHCFIVE
| Q4 25 | 16.7% | 4.2% | ||
| Q3 25 | 14.9% | 5.1% | ||
| Q2 25 | 16.2% | 5.2% | ||
| Q1 25 | 16.4% | 17.7% | ||
| Q4 24 | 14.3% | -0.1% | ||
| Q3 24 | 13.6% | 5.0% | ||
| Q2 24 | 14.3% | 4.5% | ||
| Q1 24 | 13.6% | 20.1% |
净利率EHCFIVE
| Q4 25 | 9.5% | 3.5% | ||
| Q3 25 | 8.6% | 4.2% | ||
| Q2 25 | 9.7% | 4.2% | ||
| Q1 25 | 10.4% | 13.5% | ||
| Q4 24 | 8.6% | 0.2% | ||
| Q3 24 | 8.0% | 4.0% | ||
| Q2 24 | 8.8% | 3.9% | ||
| Q1 24 | 8.5% | 15.1% |
每股收益（稀释后）EHCFIVE
| Q4 25 | $1.43 | $0.66 | ||
| Q3 25 | $1.24 | $0.77 | ||
| Q2 25 | $1.39 | $0.75 | ||
| Q1 25 | $1.48 | $3.40 | ||
| Q4 24 | $1.18 | $0.03 | ||
| Q3 24 | $1.06 | $0.60 | ||
| Q2 24 | $1.12 | $0.57 | ||
| Q1 24 | $1.10 | $3.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $524.5M |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $2.4B | $2.0B |
| 总资产 | $7.1B | $4.8B |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势，按日历期对齐
现金及短期投资EHCFIVE
| Q4 25 | $72.2M | $524.5M | ||
| Q3 25 | $48.7M | $670.2M | ||
| Q2 25 | $99.1M | $624.0M | ||
| Q1 25 | $95.8M | $528.8M | ||
| Q4 24 | $85.4M | $216.6M | ||
| Q3 24 | $147.8M | $327.7M | ||
| Q2 24 | $154.4M | $369.6M | ||
| Q1 24 | $134.4M | $460.1M |
总债务EHCFIVE
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益EHCFIVE
| Q4 25 | $2.4B | $2.0B | ||
| Q3 25 | $2.4B | $1.9B | ||
| Q2 25 | $2.3B | $1.9B | ||
| Q1 25 | $2.2B | $1.8B | ||
| Q4 24 | $2.1B | $1.6B | ||
| Q3 24 | $2.0B | $1.6B | ||
| Q2 24 | $1.8B | $1.6B | ||
| Q1 24 | $1.7B | $1.6B |
总资产EHCFIVE
| Q4 25 | $7.1B | $4.8B | ||
| Q3 25 | $6.9B | $4.6B | ||
| Q2 25 | $6.8B | $4.5B | ||
| Q1 25 | $6.6B | $4.3B | ||
| Q4 24 | $6.5B | $4.2B | ||
| Q3 24 | $6.5B | $4.0B | ||
| Q2 24 | $6.4B | $3.9B | ||
| Q1 24 | $6.2B | $3.9B |
负债/权益比EHCFIVE
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $-80.1M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $-133.2M |
| 自由现金流率自由现金流/营收 | 7.6% | -12.8% |
| 资本支出强度资本支出/营收 | 14.8% | 5.1% |
| 现金转化率经营现金流/净利润 | 2.37× | -2.19× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $323.0M |
8季度趋势，按日历期对齐
经营现金流EHCFIVE
| Q4 25 | $346.0M | $-80.1M | ||
| Q3 25 | $270.8M | $93.0M | ||
| Q2 25 | $270.2M | $132.7M | ||
| Q1 25 | $288.6M | $363.5M | ||
| Q4 24 | $278.8M | $-30.6M | ||
| Q3 24 | $267.8M | $71.3M | ||
| Q2 24 | $217.4M | $26.4M | ||
| Q1 24 | $238.8M | $407.7M |
自由现金流EHCFIVE
| Q4 25 | $116.7M | $-133.2M | ||
| Q3 25 | $83.7M | $48.3M | ||
| Q2 25 | $113.3M | $96.5M | ||
| Q1 25 | $125.5M | $311.4M | ||
| Q4 24 | $80.1M | $-111.0M | ||
| Q3 24 | $120.3M | $-32.4M | ||
| Q2 24 | $60.5M | $-61.4M | ||
| Q1 24 | $99.4M | $304.6M |
自由现金流率EHCFIVE
| Q4 25 | 7.6% | -12.8% | ||
| Q3 25 | 5.7% | 4.7% | ||
| Q2 25 | 7.8% | 9.9% | ||
| Q1 25 | 8.6% | 22.4% | ||
| Q4 24 | 5.7% | -13.2% | ||
| Q3 24 | 8.9% | -3.9% | ||
| Q2 24 | 4.6% | -7.6% | ||
| Q1 24 | 7.6% | 22.8% |
资本支出强度EHCFIVE
| Q4 25 | 14.8% | 5.1% | ||
| Q3 25 | 12.7% | 4.4% | ||
| Q2 25 | 10.8% | 3.7% | ||
| Q1 25 | 11.2% | 3.7% | ||
| Q4 24 | 14.1% | 9.5% | ||
| Q3 24 | 10.9% | 12.5% | ||
| Q2 24 | 12.1% | 10.8% | ||
| Q1 24 | 10.6% | 7.7% |
现金转化率EHCFIVE
| Q4 25 | 2.37× | -2.19× | ||
| Q3 25 | 2.14× | 2.17× | ||
| Q2 25 | 1.90× | 3.22× | ||
| Q1 25 | 1.90× | 1.94× | ||
| Q4 24 | 2.31× | -18.13× | ||
| Q3 24 | 2.48× | 2.16× | ||
| Q2 24 | 1.91× | 0.84× | ||
| Q1 24 | 2.12× | 2.02× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
FIVE
暂无分部数据
